Associate Sponsors

Co-sponsor

Lupin Q2 net up 58% at Rs 662 cr

Consolidated total income jumps 29% to Rs 4,290 cr

Lupin receives US FDA for electrolyte replenisher
Press Trust of India New Delhi
Last Updated : Nov 09 2016 | 3:21 PM IST
Drug firm Lupin today reported a 57.75% rise in its consolidated net profit to Rs 662.19 crore for the second quarter ended September 30, mainly on account of robust sales.

The company had posted a net profit after taxes and minority interest of Rs 419.75 crore for the same period of the previous fiscal, Lupin said in a BSE filing.

Consolidated total income of the company also rose to Rs 4,290.51 crore during the quarter under consideration as against Rs 3,329.67 crore in the corresponding period last fiscal.

Shares of Lupin were trading 0.81% up at Rs 1,521.55 apiece on BSE.

More From This Section

First Published: Nov 09 2016 | 3:20 PM IST

Next Story